Biotech Valuation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation

CRSP 52.20

-5.5%

Nov 12 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jim Oravetz who wrote (890)	3/24/2000 5:30:00 PM
From: Biomaven	Read Replies (1) of 52153

When analyzing a biotechnology stock, it is best to take cues from the lawyers who write prospectuses Chuckle. That's about as sensible as taking your cues from the Yahoo pump'n'dump artists. "We don't have any products ... we may never have any products ... even if we (courtesy some divine intervention) eventually had a product the FDA might not approve it ... we could get sued .... we could run out of money ... our patent rights are uncertain ... our key scientists might walk... our competitors are all much bigger and better than us ..." Sound like any biotechs you know? Peter

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next